27th week of 2020 patent applcation highlights part 26 |
Patent application number | Title | Published |
20200207838 | SINGLE CHAIN VH AND HEAVY CHAIN ANTIBODIES - The present invention provides cells, transgenic animals, including transgenic mammals and particularly rodents comprising engineered immunoglobulin (Ig) alleles. Such engineered alleles, wherein an Ig light chain CL exon [Cκ or Cλ (Cλ1, Cλ2 or Cλ3)] is incorporated into the Ig heavy chain locus, are capable of producing heavy chain-only antibodies as a single chain VH antibody (scVHAb) or heavy chain antibody (HCAb) comprising two extended scVHAbs. The scVHAb comprises an antigen-binding part consisting of a VH domain and the immunoglobulin constant domains CL, which is either Cκ or Cλ, and CH1, in the order from N-terminus to C-terminus: VH-L1-CL-L2-CH1, wherein L1 and L2 are each, independently, peptidic linkers; and wherein CL is paired with CH1 through beta-sheet contact thereby obtaining a CL/CH1 dimer. | 2020-07-02 |
20200207839 | IMMUNOGLOBULIN PURIFICATION - The current invention reports a method for purifying an immunoglobulin, wherein the method comprises applying an aqueous, buffered solution comprising an immunoglobulin in monomeric, in aggregated, and in fragmented form to an anion exchange chromatography material under conditions whereby the immunoglobulin in monomeric form does not bind to the anion exchange material, and recovering the immunoglobulin in monomeric form in the flow-through from the anion exchange chromatography material, whereby the buffered aqueous solution has a pH value of from 8.0 to 8.5. In one embodiment the anion exchange chromatography material is a membrane anion exchange chromatography material. | 2020-07-02 |
20200207840 | DETECTION OF CHO-MIF CONTAMINATIONS - The invention concerns a detection method to enable the detection of complexes formed between antibodies and antigen which is endogenous to the production cell line, e.g. CHO MIF in a final product. | 2020-07-02 |
20200207841 | NOVEL FULL SPECTRUM ANTI-DENGUE ANTIBODY - The present invention provides, among other things, antibody agents (e.g., antibodies, and/or antigen-binding fragments thereof) that bind to DV epitopes, as well as compositions containing them and methods of designing, providing, formulating, using, identifying and/or characterizing them. In some embodiments, provided antibody agents show significant binding to a plurality of DV serotypes. In some embodiments, provided antibody agents show significant binding to all four DV serotypes. Such antibody agents are useful, for example, in the prophylaxis, treatment, diagnosis, and/or study of DV. | 2020-07-02 |
20200207842 | ANTI-C5A ANTIBODIES - The present disclosure relates to, inter alia, antibodies, or antigen-binding fragments thereof, that bind to C5a and to use of the antibodies in methods for treating or preventing complement-associated disorders such as, but not limited to, atypical hemolytic uremic syndrome, age-related macular degeneration, rheumatoid arthritis, sepsis, severe burn, antiphospho lipid syndrome, asthma, lupus nephritis, Goodpasture's syndrome, and chronic obstructive pulmonary disease. | 2020-07-02 |
20200207843 | ANTI-TAU CONSTRUCTS - The present invention provides anti-tau constructs. Anti-tau constructs of the invention are polynucleotide sequences encoding a polypeptide comprising at least one tau binding moiety and optionally comprising a signal peptide and/or a purification moiety. The present invention also provides isolated polypeptides encoded by anti-tau constructs, vectors comprising anti-tau constructs, and isolated cells comprising said vectors. | 2020-07-02 |
20200207844 | ANTI-VEGF ANTIBODY - This disclosure relates to antibodies and antigen-binding fragments that bind specifically to Vascular endothelial growth factor (VEGF), and prophylactic, diagnostic, and therapeutic methods of using the same. | 2020-07-02 |
20200207845 | ANG2-BINDING MOLECULES - Ang2-binding molecules, preferably Ang2-binding immunoglobulin single variable domains like VHHs and domain antibodies, pharmaceutical compositions containing same and their use in the treatment of diseases that are associated with Ang2-mediated effects on angiogenesis. Nucleic acids encoding Ang2-binding molecules, host cells and methods for preparing same. | 2020-07-02 |
20200207846 | LIGAND-BINDING MOLECULE HAVING ADJUSTABLE LIGAND BINDING ACTIVITY - The present invention relates to a ligand binding molecule whose ligand binding activity is attenuated by the cleavage of a cleavage site and a method for producing the same, a complex formed by the ligand binding molecule and a ligand, a fusion protein comprising the ligand binding molecule and a ligand, and a pharmaceutical composition comprising the ligand binding molecule or a fusion protein of the ligand binding molecule and a ligand. | 2020-07-02 |
20200207847 | IL-11RA ANTIBODIES - IL-11Ra antibodies are disclosed. Also disclosed are compositions comprising the IL-11Ra antibodies, and methods using the IL-11Ra antibodies. | 2020-07-02 |
20200207848 | USE OF IL-1B BINDING ANTIBODIES FOR THE TREATMENT OF ALCOHOLIC HEPATITIS - The present invention relates to a method for treating or alleviating the symptoms of alcoholic hepatitis in a subject, comprising administering gevokizumab or 2-5 mg of canakinumab per kg of body weight to a subject in need thereof. | 2020-07-02 |
20200207849 | NOVEL ENGINEERED T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME - The present invention pertains to antigen recognizing constructs against COL6A3 antigens. The invention in particular provides novel engineered T cell receptor (TCR) based molecules which are selective and specific for the tumor expressing antigen COL6A3. The TCR of the invention, and COL6A3 antigen binding fragments derived therefrom, are of use for the diagnosis, treatment and prevention of COL6A3 expressing cancerous diseases. Further provided are nucleic acids encoding the antigen recognizing constructs of the invention, vectors comprising these nucleic acids, recombinant cells expressing the antigen recognizing constructs and pharmaceutical compositions comprising the compounds of the invention. | 2020-07-02 |
20200207850 | MULTI-CHAIN POLYPEPTIDE-CONTAINING TRI-SPECIFIC BINDING MOLECULES THAT SPECIFICALLY BIND TO MULTIPLE CANCER ANTIGENS - The present invention relates to Tri-Specific Binding Molecules, which are multi-chain polypeptide molecules that possess three Binding Domains and are thus capable of mediating coordinated binding to three epitopes. The Binding Domains may be selected such that the Tri-Specific Binding Molecules are capable of binding to any three different epitopes. Such epitopes may be epitopes of the same antigen or epitopes of two or three different antigens. In a preferred embodiment, one of such epitopes will be capable of binding to CD3, the second of such epitopes will be capable of binding to CD8, and the third of such epitopes will be capable of binding to an epitope of a Disease-Associated Antigen. The invention also provides a novel ROR1-binding antibody, as well as derivatives thereof and uses for such compositions. | 2020-07-02 |
20200207851 | TRIFUNCTIONAL MOLECULE AND APPLICATION THEREOF - This disclosure belongs to the field of biomedical technology, and particularly refers to a trifunctional molecule and the application thereof. The structure of the trifunctional molecule includes a first functional domain, a second functional domain and a third functional domain. These domains are capable of simultaneously binding to CD19, CD3, and T cell positive (negative) costimulatory factors, thereby producing the first and second signal required for T cell activation. The trifunctional molecule is a recombinant protein peptide chain, which can be produced by a eukaryotic cell expression system. The product has a single structure, simple purification process, high protein yield, and preparation process and product stability. The trifunctional molecule is superior to the anti-CD19/anti-CD3 BiTE bispecific antibody in killing CD19-positive target cells. Compared with the CAR-T technology targeting CD19, the trifunctional molecule is more convenient to use, the dose is controllable, and the side effects of CAR-T are avoided. | 2020-07-02 |
20200207852 | T CELLS EXPRESSING A CHIMERIC ANTIGEN RECEPTOR - Described herein are methods for producing and utilizing T cells comprising chimeric antigen receptors (CAR) comprising an extracellular domain that binds CD79b, or CD79b and CD 19. Further, this invention is related to methods of treating cancer, plasma cell diseases or disorders, or autoimmune diseases or disorders. | 2020-07-02 |
20200207853 | ANTI-CD47 ANTIBODIES AND USES THEREOF - Anti-CD47 antibodies and antigen-binding fragments thereof are described. Also described are nucleic acids encoding the antibodies, compositions comprising the antibodies, and methods of producing the antibodies and using the antibodies for treating or preventing diseases such as cancer, inflammatory disease, infectious disease, atherosclerosis, cardiovascular disease, metabolic disease, radiation-induced injury, and/or autoimmune disease. | 2020-07-02 |
20200207854 | HUMANIZED AFFINITY MATURED ANTI-FcRn ANTIBODIES - Provided herein are recombinant antibodies and antigen-binding portions thereof useful for binding to FcRn and blocking binding of FcRn to IgG Fc. The FcRn-binding proteins can be used to treat a variety of disorders including autoimmune disorders. | 2020-07-02 |
20200207855 | NOVEL ANTIBODIES AND COMBINED USE OF A TREG DEPLETING ANTIBODY AND AN IMMUNOSTIMULATORY ANTIBODY - Described is the sequential administration of first a Treg depleting antibody molecule selected from antibody molecules, such as an antibody molecule binding specifically to target belonging to the tumour necrosis factor receptor superfamily (TNFRSF), such as a Treg depleting anti-4-1 BB antibody or a Treg depleting OX-40 antibody, and then an immunostimulatory antibody molecule, such as an immunostimulatory anti-4-1 BB anti-body or an immunostimulatory OX-40 antibody, for use in the treatment of cancer. Described are also novel anti-4-1 BB antibodies and novel OX-40 antibodies that may be used in such sequential administration. | 2020-07-02 |
20200207856 | ANTIBODIES TO LILRB2 - Provided herein are various embodiments relating to antibodies that bind LILRB2. Anti-LILRB2 antibodies can be used in methods to treat disease, for example, cancer. | 2020-07-02 |
20200207857 | BINDING MOLECULES SPECIFIC FOR CLAUDIN 18.2, COMPOSITIONS AND METHODS THEREOF, FOR THE TREATMENT OF CANCER AND OTHER DISEASES - Compositions and methods of making isolated binding molecules (e.g. an antibodies) or antigen-binding fragment thereof useful as therapeutics for treating and/or preventing diseases associated with cells expressing claudin18.2, including tumor-related diseases such as gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, and cancer of the gallbladder are described. Also, described are pharmaceutical formulations comprising the described compositions for the treatment of diseases either as single agent (e.g., naked antibodies) or as adjuvant therapy with other antigen-binding anticancer agents such as immune checkpoint inhibitors (e.g., anti-CTLA-4 and anti-PD-1/PD-L1 monoclonal antibodies), and/or by combination therapies where the anti-claudin18.2 antibodies are administered before, after, or concurrently with chemotherapy. | 2020-07-02 |
20200207858 | ANTIBODIES CAPABLE OF BINDING HLA-A2/TYRD IN AN HLA RESTRICTED MANNER AND USES THEREOF - Antibodies capable of binding HLA-A2/Tyrosinase (TyrD) in an HLA restricted manner are provided. Specifically, the antibodies are capable of binding HLA-A2/TyrD369-377 in an HLA restricted manner. Further provided are complementary determining region (CDR) sequences of heavy chain and light chain of antibodies, and methods of using the antibodies for the treatment of cancer. | 2020-07-02 |
20200207859 | METHODS OF USING ANTI-CD74 ANTIBODIES AND ANTIBODY CONJUGATES IN TREATMENT OF T-CELL LYMPHOMA - Provided herein are antibody conjugates with binding specificity for CD74 and compositions comprising the antibody conjugates, including pharmaceutical compositions, methods of producing the conjugates, and methods of using the conjugates and compositions for therapy involving treatment, amelioration, and/or diagnosis of a T-cell lymphoma. | 2020-07-02 |
20200207860 | EXTRA LUMINAL SCAFFOLD - Methods and devices for treating a luminal pathology affecting an anatomical lumen of a patient comprising forming, in situ, a continuous cohesive layer of covalently-crosslinked hydrogel in a luminal wall of the anatomical lumen. | 2020-07-02 |
20200207861 | METHOD OF INHIBITION OF LEUKEMIC STEM CELLS - A method for inhibition of leukemic stem cells expressing IL-3Rα (CD123), comprises contacting the cells with an antigen binding molecule comprising a Fc region or a modified Fc region having enhanced Fc effector function, wherein the antigen binding molecule binds selectively to IL-3Rα (CD123). The invention includes the treatment of a hematologic cancer condition in a patient by administration to the patient of an effective amount of the antigen binding molecule. | 2020-07-02 |
20200207862 | ANTI-IL-36R ANTIBODIES FOR TREATMENT OF PALMOPLANTAR PUSTULOSIS - The present invention relates to the treatment of or alleviation of signs and symptoms of palmoplantar pustulosis (PPP) with anti-IL-36R antibodies in a patient. | 2020-07-02 |
20200207863 | HUMAN BLADDER CANCER MARKER AG-CD71 AND ANTIBODY ABC71 AND APPLICATION THEREOF - A novel human bladder cancer marker AG-CD71 and a monoclonal antibody ABC71 for preventing AG-CD71 are provided. The human bladder cancer marker AG-CD71 is an abnormal glycosylated transferrin receptor TFRC; the abnormal glycosylated transferrin receptor TFRC refers to the TFRC carrying a saccharide structure Fucal-4(GlcNAcbl-3)[6OSO3]GlcNAc as an epitope. Also provided is an antibody for the human bladder cancer marker AG-CD71; the antibody is the monoclonal antibody ABC71 specific for the human bladder cancer AG-CD71; the monoclonal antibody is secreted from the hybridoma cell to strain the preservation number of which is CGMCC No. 14312. | 2020-07-02 |
20200207864 | METHODS FOR TREATING NEPHROTIC SYNDROME - Described herein are methods for treating nephrotic syndrome using an anti-CD20 antibody. In one embodiment, that anti-CD20 antibody is Obinutuzumab. | 2020-07-02 |
20200207865 | CYTOTOXIC AND ANTI-MITOTIC COMPOUNDS, AND METHODS OF USING THE SAME - Compounds having cytotoxic and/or anti-mitotic activity are disclosed. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed. Also disclosed are compositions having the structure: (T)-(L)-(D), wherein (T) is a targeting moiety, (L) is an optional linker, and (D) is a compound having cytotoxic and/or anti-mitotic activity. | 2020-07-02 |
20200207866 | ANTI-TLR4 ANTIBODIES AND USES THEREOF - Disclosed are antibodies that specifically bind Toll-like Receptor 4 (TLR-4), and to methods of using the anti-TLR4 antibodies as therapeutics and diagnostic agents. | 2020-07-02 |
20200207867 | HEAVY CHAIN ANTIBODIES BINDING TO ECTOENZYMES - Human heavy chain antibodies, such as UniAbs™, binding to ectoenzymes are provided along with combinations of such heavy chain antibodies and multi-specific heavy chain antibodies, targeting non-overlapping epitopes on ectoenzymes, including synergistic combinations. Methods of making such antibodies, compositions including pharmaceutical compositions comprising such antibodies, and methods directed to the treatment of disease or conditions associated with the expression of ectoenzymes are also included. | 2020-07-02 |
20200207868 | HER3 BINDING AGENTS AND USES THEREOF - The disclosure is directed to antibodies and binding fragments thereof that specifically bind HER3. The disclosure is further directed to immunoconjugates comprising the antibodies and binding fragments thereof that specifically bind HER3. The disclosure is also directed to uses of the antibodies, binding fragments thereof and immunoconjugates for detecting HER3-expressing cells and for treating HER3-expressing cancer. | 2020-07-02 |
20200207869 | ANTI-VWF D'D3 SINGLE-DOMAIN ANTIBODIES AND POLYPEPTIDES COMPRISING THEREOF - The invention relates to isolated single-domain antibodies (sdAb) directed against von Willebrand Factor (VWF) D′D3 domain and chimeric polypeptides comprising thereof such as blood clotting factors and their uses in therapy such as in the prevention and treatment of hemostatic disorders. The invention also relates to a method of extending or increasing half-life of a therapeutic polypeptide comprising a step of adding to the polypeptide sequence of said therapeutic polypeptide at least one sdAb directed against VWF D′D3 domain. | 2020-07-02 |
20200207870 | NEUKINASE, A DOWNSTREAM PROTEIN OF NEUREGULIN - The present invention relates to neukinase, a downstream protein kinase in the neuregulin signaling pathway. In certain aspects, the present invention provides isolated neukinase-encoding nucleic acids, neukinase polypeptides, oligonucleotides that hybridize to neukinase nucleic acids, and expression vectors containing neukinase-encoding sequences. The present invention further provides isolated host cells, antibodies, transgenic non-human animals, compositions, and kits relating to neukinase. In other aspects, the present invention further provides methods of identifying predisposition to cardiac dysfunction, methods of detecting the presence of neukinase, neukinase nucleic acid, methods of screening for agents which affect neukinase activity, and methods of modulating neukinase activity. | 2020-07-02 |
20200207871 | Inhibition of Vascular Matrix Metalloproteinase-9 to Treat Ischemic Injury - Methods and pharmaceutical compositions for treating ischemic injury are provided. The methods include administering a therapeutically effective amount of a vascular matrix metalloproteinase 9 (MMP-9) inhibitor that reduces ischemic injury in a subject. | 2020-07-02 |
20200207872 | METHODS FOR TREATING INFLAMMATION AND RELATED DISEASES AND DISORDERS BY INHIBITING ALPHA PROTEIN KINASE 1 - The disclosure provides methods related to inhibiting alpha-kinase 1 (ALPK1) for treating inflammation and inflammatory diseases, disorders, and conditions, as well as for treating an autoimmune disease, a disease or disorder caused by a bacterial infection, or cancer. | 2020-07-02 |
20200207873 | ANTIBODIES AND PEPTIDES TO TREAT HCMV RELATED DISEASES - The present invention relates to the treatment of HCMV relates diseases. The inventors conducted a study to find an essential domain of pUL56 for its interaction with pUL89 which is important in the effect of the CMV. Sequences alignments allowed them to predict one sequence in C-terminal of pUL56 potentially necessary for interaction with pUL89. BAC mutagenesis and AlphaLISA technologies using purified proteins allowed to validate that the short sequence | 2020-07-02 |
20200207874 | POLYPEPTIDE-POLYNUCLEOTIDE-COMPLEX AND ITS USE IN TARGETED EFFECTOR MOIETY DELIVERY - Herein is reported a polypeptide-polynucleotide-complex as therapeutic agent and its use as tool for the targeted delivery of an effector moiety. The polynucleotide part of the complex is essentially resistant to proteolytic and enzymatic degradation in vivo. Additionally the polypeptide part specifically binds to a compound or structure such as a tissue or organ, a process or a disease. Thus, one aspect as reported herein is a polypeptide-polynucleotide-complex comprising a) a polypeptide specifically binding to a target and conjugated to a first member of a binding pair, b) a polynucleotide linker conjugated at its first terminus to the second member of the binding pair, and c) an effector moiety conjugated to a polynucleotide that is complementary to at least a part of the polynucleotide linker. | 2020-07-02 |
20200207875 | METHOD FOR PREPARING RECOMBINANT PROTEIN FROM BACTERIUM AND COMPOSITION CONTAINING THE SAME - Methods for preparing a recombinant protein from a bacterium are provided. The method includes constructing an expression vector including two promoters. Each of the two promoters attaches a secretion signal peptide to one polypeptide of a protein. The protein attached with the two promoters and secretion signal peptides is then cloned into the expression vector to provide a recombinant expression plasmid. The recombinant expression plasmid is transformed into a host cell. A fermentation process is performed to grow the host cell and to induce an expression to synthesize polypeptides in the host cell and to transport the polypeptides to an outside of a cytoplasm of the host cell, such that the polypeptides are released in a soluble form in a growth medium of the host cell. The polypeptides are assembled into a three-dimensional structure of the protein. The protein is captured from the growth medium. | 2020-07-02 |
20200207876 | Nanocomposite bacteriostatic material and a preparation method and an application thereof - The present invention discloses a novel nano-composite antibacterial material and a preparation method and an application thereof, and belongs to the technical field of preservative materials. The novel nano-composite antibacterial material disclosed by the present invention is prepared by mixing a dimethylimidazole solution, deionized water and a zinc nitrate solution to prepare a metal-organic framework carrier, compositing with nisin to form a nano antibacterial composite material, separating out from a solution in a precipitate form, centrifuging, removing a supernatant, cleaning and re-suspending with the deionized water. The novel nano-composite antibacterial material prepared by the present invention has an antibacterial effect superior to nisin having a same concentration. The present invention prominently improves an antibacterial activity and thermostability of the nisin under neutral and slightly alkaline conditions, effectively promotes antibacterial property and a usable range of the nisin, and further expands an application field of the metal-organic framework carrier. | 2020-07-02 |
20200207877 | Thermally Inhibited Starch and Process for Making - Improved thermally inhibited starch is disclosed and methods of making such starch are disclosed. In some embodiments a thermally inhibited starch has improved whiteness and flavor. In some embodiments a method for making a thermally inhibited starch includes providing adding a buffer and an acid to a starch to obtain a pH adjusted starch having an acidic pH and thermally inhibiting the pH adjusted starch. The technology further pertains to methods of making the thermally inhibited starch in batch, continuous, continuous-like process or combinations thereof. | 2020-07-02 |
20200207878 | AMYLASE-DEGRADED ORGANIC ACID ANHYDRIDE SUBSTITUTED STARCHES AND METHODS OF PREPARING THE SAME - Water soluble, lipophilic starches are provided, which comprise a mixture of functionalized high and low molecular weight maltodextrin molecules. The starches may be formed by dispersing a granular starch in a liquid medium to form a slurry that is simultaneously cooked and subjected to enzyme hydrolysis. Following hydrolysis, the starch is functionalized with an organic acid anhydride reagent, such as octenylsuccinic anhydride. The organic acid anhydride substitution occurs randomly and at various locations within the maltodextrin molecules. | 2020-07-02 |
20200207879 | POLYMERIZATION REACTOR SYSTEM COMPRISING AT LEAST ONE WITHDRAWAL VALVE - Described herein is a polymerization reactor system comprising at least one loop reactor and/or at least one transfer line, and further comprising at least one withdrawal valve, wherein the at least one withdrawal valve is mounted to a wall of a lower horizontal segment of the loop reactor and/or to a wall of the transfer line, at an angle α of more than 0° and equal to or less than 85°, determined from perpendicular to a tangent of the wall at the mounting position in flow direction of a slurry in the loop reactor and/or in the transfer line. The valve piston of the at least one withdrawal valve comprises a valve plate at an end directed to the at least one loop reactor and/or at an end directed to the at least one transfer line, the valve plate being shaped according to an inner wall of the at least one loop reactor and/or according to an inner wall of the at least one transfer line such that the valve piston is flush with the inner wall of the at least one loop reactor and/or with the inner wall of the at least one transfer line in a closed position of the withdrawal valve. By using such a withdrawal valve, a limitation of the effective withdrawal area can be avoided or at least be reduced such that the liquid slurry can efficiently be withdrawn and the risk of plugging is reduced. Further disclosed is a method for producing an olefin polymer in the inventive polymerization reactor system. | 2020-07-02 |
20200207880 | METHOD FOR PRODUCING MODIFIED POLYTETRAFLUOROETHYLENE, METHOD FOR PRODUCING MODIFIED POLYTETRAFLUOROETHYLENE POWDER, AND METHOD FOR PRODUCING STRETCHED POROUS MATERIAL - To provide a novel method for producing a modified PTFE. | 2020-07-02 |
20200207881 | LIQUID COMPOSITION, DEVICE, METHOD OF MANUFACTURING POROUS RESIN, POROUS RESIN, PRODUCT, AND METHOD OF MANUFACTURING POROUS RESIN - A liquid composition that contains a polymerizable compound and a solvent, and that can form a porous resin. The liquid composition, when stirred, transmits at least 30 percent of incident light having a wavelength of 550 nm. The haze value of an containing the liquid composition increases by 1.0 percent or more when the element containing the liquid composition is cured. | 2020-07-02 |
20200207882 | Multiple Reactor and Multiple Zone Polyolefin Polymerization - Apparatuses and processes that produce multimodal polyolefins, and in particular, polyethylene resins, are disclosed herein. This is accomplished by using two reactors in series, where one of the reactors is a multi-zone circulating reactor that can circulate polyolefin particles through two polymerization zones optionally having two different flow regimes so that the final multimodal polyolefin has improved product properties and improved product homogeneity. | 2020-07-02 |
20200207883 | Multiple Reactor and Multiple Zone Polyolefin Polymerization - Apparatuses and processes that produce multimodal polyolefins, and in particular, polyethylene resins, are disclosed herein. This is accomplished by using two reactors in series, where one of the reactors is a multi-zone circulating reactor that can circulate polyolefin particles through two polymerization zones optionally having two different flow regimes so that the final multimodal polyolefin has improved product properties and improved product homogeneity. | 2020-07-02 |
20200207884 | MULTIPLE REACTOR AND MULTIPLE ZONE POLYOLEFIN POLYMERIZATION - Apparatuses and processes that produce multimodal polyolefins, and in particular, polyethylene resins, are disclosed herein. This is accomplished by using two reactors in series, where one of the reactors is a multi-zone circulating reactor that can circulate polyolefin particles through two polymerization zones optionally having two different flow regimes so that the final multimodal polyolefin has improved product properties and improved product homogeneity. | 2020-07-02 |
20200207885 | MULTIPLE REACTOR AND MULTIPLE ZONE POLYOLEFIN POLYMERIZATION - Apparatuses and processes that produce multimodal polyolefins, and in particular, polyethylene resins, are disclosed herein. This is accomplished by using two reactors in series, where one of the reactors is a multi-zone circulating reactor that can circulate polyolefin particles through two polymerization zones optionally having two different flow regimes so that the final multimodal polyolefin has improved product properties and improved product homogeneity. | 2020-07-02 |
20200207886 | PROCESS FOR INTRODUCING CATALYST IN A POLYMERIZATION PROCESS - Methods of adding a catalyst to a bulk polymerization process may include mixing the catalyst with propylene to form a catalyst mixture that is substantially free of any C20 or greater hydrocarbons, feeding the catalyst mixture into a polymerization reactor, activating the catalyst mixture; and performing a polymerization on the catalyst mixture in the polymerization reactor. Polymers may be formed by polymerization processes that are substantially free of any C20 or greater hydrocarbons. | 2020-07-02 |
20200207887 | PROCESS FOR PREPARING HIGH-REACTIVITY ISOBUTENE HOMO- OR COPOLYMERS - The present invention relates to a novel process for preparing high-reactivity isobutene homo- or copolymers with a content of terminal vinylidene double bonds per polyisobutene chain end of at least 70 mol %. The present invention further relates to novel isobutene polymers. | 2020-07-02 |
20200207888 | Method of Preparing Conjugated Diene-Based Polymer and Apparatus for Preparing Conjugated Diene-Based Polymer - A method of preparing a conjugated diene-based polymer is provided. The method includes: adding a conjugated diene-based monomer, a catalyst, and a solvent to parallel polymerization reactors, performing a polymerization reaction to prepare a first polymer solution including a first conjugated diene-based polymer; and adding the first polymer solution to a polymerization reactor connected in series to the parallel polymerization reactors, performing the polymerization reaction to prepare a second polymer solution including a second conjugated diene-based polymer. After the polymerization reaction in the series polymerization reactor, gas produced by polymerization heat is condensed in the series polymerization reactor and refluxed to the parallel polymerization reactors, and a reaction temperature of the series polymerization reactor is maintained to be lower than a reaction temperature of the parallel polymerization reactors by 10° C. or more. | 2020-07-02 |
20200207889 | LOW DENSITY ETHYLENE-BASED POLYMERS FOR LOW SPEED EXTRUSION COATING OPERATIONS - A polyethylene homopolymer comprising the following properties: a) a melt index (I2) from 1.0 to 3.5 dg/min; b) a Mw(abs) versus I2 relationship: Mw(abs)≥A+B(I2), where A=3.20×10 | 2020-07-02 |
20200207890 | PHOTOCURABLE RESIN COMPOSITION - A photocurable resin composition which can improve adhesion between light transmitting members. The photocurable resin composition contains a monofunctional acrylic monomer having a heating residue of 85.0% or less after being heated at 60° C. for 30 minutes, a crosslinking agent, a photopolymerization initiator, and a softening agent composed of at least one of plasticizer and tackifier, and the heating residue after being heated at 60° C. for 30 minutes is less than 96.0%. | 2020-07-02 |
20200207891 | PROCESS FOR THE PREPARATION OF 1,2 SYNDIOTACTIC POLYBUTADIENE IN THE PRESENCE OF A CATALYTIC SYSTEM COMPRISING A COBALT COMPLEX WITH A PHOSPHINE LIGAND - Process for the preparation of 1,2 syndiotactic polybutadiene comprising polymerizing 1,3-butadiene in the presence of a catalytic system comprising: at least one cobalt complex with a phosphine ligand having general formula (I): wherein: R | 2020-07-02 |
20200207892 | Silica-Coated Alumina Activator-Supports For Metallocene Catalyst Compositions - Silica-coated alumina activator-supports, and catalyst compositions containing these activator-supports, are disclosed. Methods also are provided for preparing silica-coated alumina activator-supports, for preparing catalyst compositions, and for using the catalyst compositions to polymerize olefins. | 2020-07-02 |
20200207893 | CURABLE FLUOROELASTOMER COMPOSITION - Fluoroelastomer compositions comprising fluoroelastomers having copolymerized units of a nitrile-containing cure site monomer are cured with certain hydrazone or oxime curatives. | 2020-07-02 |
20200207894 | ALKYL-MODIFIED CARBOXYL GROUP-CONTAINING COPOLYMER, THICKENER CONTAINING SAID COPOLYMER, AND METHOD FOR PREPARING SAID COPOLYMER - Provided is an alkyl-modified carboxyl group-containing copolymer with which a neutralized viscous liquid can be prepared which has excellent dispersibility in water, has a viscosity that does not change greatly regardless of addition of an electrolyte, and has high transparency in the presence of an electrolyte. This alkyl-modified carboxyl group-containing copolymer contains: 100 parts by mass of a (meth)acrylic acid; 1.5-4.5 parts by mass of a (meth)acrylic acid alkyl ester, in which an alkyl group has 18-24 carbon atoms; and 0-0.1 parts by mass of a compound having two or more ethylenically unsaturated groups, wherein the copolymer contains 1.5-4.5 parts by mass of a nonionic surfactant. | 2020-07-02 |
20200207895 | RADICALLY POLYMERIZABLE COMPOSITIONS - Polymerizable compositions comprising a radically polymerizable resin can be polymerized in the absence of a peroxide initiator and other undesirable components. The polymerizable compositions and methods employ a manganese- or iron-containing salt or organic complex and a 1,3-dioxo compound with one or more other components. The polymerizable compositions have better storage stability and reduced gel time-drift. | 2020-07-02 |
20200207896 | MIXED-CHARGE POLYMERS - A composition contains a mixed-charge polymer comprising independent pendant quaternary ammonium functionalities and pendant carboxylate functionalities extending from the polymer backbone, wherein the composition comprises less than one weight-percent chloride relative to composition weight. | 2020-07-02 |
20200207897 | STYRENE RESIN AND METHOD FOR PRODUCING STYRENE RESIN - The present invention relates to a styrene-based resin having a weight average molecular weight Mw′ as determined by the GPC-MALS method of 1,000,000 or more and 5,000,000 or less, a degree of long-chain branching of 0.2 or more per 1,000 styrene units, and a tetrahydrofuran-insoluble matter of 0.1% by weight or less (including 0), the styrene-based resin being free from a component derived from a polyfunctional monomer in a molecular chain thereof. In a method for producing this styrene-based resin, in an impregnation step of adding a polymerization initiator and a styrene monomer in an aqueous medium, thereby impregnating the polymerization initiator and the styrene monomer in the seed particle at a temperature at which polymerization of the styrene monomer does not substantially proceed, the amount of the styrene monomer is 20 to 200 parts by weight based on 100 parts by weight of the seed particle; and in an additional impregnation polymerization step of graft polymerizing the styrene monomer on the styrene-based resin, the addition amount of the styrene monomer is 50 to 700 parts by weight based on 100 parts by weight of the seed particle, and the content of the styrene monomer in the seed particle is held at 10% by weight or less. | 2020-07-02 |
20200207898 | COMPOSITION AND POSITIVE-ELECTRODE BINDER COMPOSITION - An object of the present invention is to provide a composition having flexibility. A composition comprising a graft copolymer in which a monomer, including a (meth) acrylonitrile and a (meth) acrylic acid ester as a main monomer, graft-copolymerizes to a backbone polymer having a polyvinyl alcohol, wherein the polyvinyl alcohol has a saponification degree of 50 to 100 mol %, a content of the composition of the polyvinyl alcohol is 5 to 50% by mass, a total content of the (meth) acrylonitrile monomer unit and the (meth) acrylic acid ester monomer unit is 50 to 95% by mass, a content of the (meth) acrylonitrile monomer unit in a total of 100% by mass of the (meth) acrylonitrile monomer unit and the (meth)acrylate monomer unit is 20 to 95% by mass, a content of the (meth)acrylate monomer unit in a total of 100% by mass of the (meth) acrylonitrile monomer unit and the (meth)acrylate monomer unit is 5 to 80% by mass, the (meth) acrylic acid ester is a monomer whose homopolymer has a glass transition temperature of 150 to 300 K. | 2020-07-02 |
20200207899 | THERMOSETTING RESIN COMPOSITION, PREPREG MADE THEREFROM, LAMINATE CLAD WITH METAL FOIL, AND HIGH-FREQUENCY CIRCUIT BOARD - Disclosed are a thermosetting resin composition, a prepreg made therefrom, a laminate clad with a metal foil, and a high-frequency circuit board, wherein the thermosetting resin composition contains thermosetting ingredients. The thermosetting ingredients include a phosphorus-containing monomer or a phosphorus-containing resin and another thermosetting resin containing an unsaturated group, and the phosphorus-containing monomer or the phosphorus-containing resin has a structure as shown in formula I. By using the phosphorus-containing monomer or the phosphorus-containing resin as a cross-linking agent of the other thermosetting resin containing an unsaturated group and by means of a cross-linking reaction of a large number of unsaturated double bonds in the resin, the high-frequency dielectric properties and high-temperature-resistance required by a circuit substrate are provided. | 2020-07-02 |
20200207900 | BLOCK COPOLYMER AND PRODUCTION METHOD FOR BLOCK COPOLYMER - Disclosed is a block copolymer including one or more blocks of an acrylate polymer and one or more blocks of a chloroprene polymer, wherein the number average molecular weight of the block copolymer is 110,000 or more, the number average molecular weight of the block of a chloroprene polymer is 80,000 or more in total, and the block copolymer has a functional group with a structure represented by the following chemical formula (1) or (2): | 2020-07-02 |
20200207901 | VINYL AROMATIC/DIENE-BLOCK COPOLYMERS HAVING GOOD ORGANOLEPTIC PROPERTIES - The invention relates to a vinyl aromatic/diene-block copolymer A, obtained by an anionic polymerization of a monomer composition, comprising: Al: 60-95 wt.-% of at least one vinyl aromatic monomer, and A2:5-40 wt.-% of at least one diene monomer, wherein the vinyl aromatic/diene-block copolymer A in total comprises less than 10 parts per million (ppm) of acetaldehyde, methacrolein and styrene based on the total amount of vinyl aromatic/diene-block copolymer A; the vinyl aromatic/diene-block copolymer A has improved orgnoleptic properties and is in particular suitable for producing food packaging materials. | 2020-07-02 |
20200207902 | POLYMER, HARDMASK COMPOSITION, AND METHOD OF FORMING PATTERNS - A polymer, a hardmask composition, and a method of forming patterns, the polymer including structural units obtained by a reaction of a reaction mixture that includes a substituted or unsubstituted indole compound, a first aromatic aldehyde compound including a substituted or unsubstituted C3 to C20 branched alkyl group thereon, and a second aromatic aldehyde compound that is different from the first aromatic aldehyde compound. | 2020-07-02 |
20200207903 | AQUEOUS POLYURETHANE DISPERSION ADHESIVE COMPOSITIONS - An aqueous polyurethane dispersion compositions are disclosed. The compositions include a polyurethane prepolymer dispersed in an aqueous medium, the polyurethane prepolymer comprising an isocyanate and a crystalline polyester polyol having a hydroxyl content of 20 to 150 mg KOH/g and a melt temperature of less than or equal to 90° C. Methods of forming a laminate are also disclosed. The methods include providing an aqueous polyurethane dispersion, applying the polyurethane dispersion to a surface of the first substrate, bringing the side of the first substrate into contract with a surface of the second substrate, and curing the aqueous dispersion, thereby laminating the first substrate to the second substrate. Laminates formed by the methods and including the compositions are also disclosed. | 2020-07-02 |
20200207904 | COMPOSITION FOR A POLISHING PAD, POLISHING PAD, AND PROCESS FOR PREPARING THE SAME - In the composition according to the embodiment, the content of an unreacted diisocyanate monomer in a urethane-based prepolymer may be controlled to control the physical properties thereof such as gelation time. Thus, since the micropore characteristics, polishing rate, and pad cut rate of a polishing pad obtained by curing the composition according to the embodiment may be controlled, it is possible to efficiently manufacture high-quality semiconductor devices using the polishing pad. | 2020-07-02 |
20200207905 | WATER-BASED ADHESIVE COMPOSITIONS - Water-based adhesive composition are disclosed, the compositions comprising an acrylic dispersion, an epoxy-terminated polyester incorporated into the acrylic dispersion, and a water-dispersible isocyanate. Methods for laminating a first substrate to a second substrate are also disclosed, the methods comprising (a) providing an acrylic dispersion, (b) providing an epoxy-terminated polyester, (c) mixing the acrylic dispersion and the epoxy-terminated polyester, (d) mixing the mixture of (c) with a water-dispersible isocyanate to form an adhesive composition, (e) coating the adhesive composition of (d) on a surface of the first substrate, (f) drying the adhesive compositions on the first substrate to remove water, and (g) bringing the adhesive composition on the surface of the first substrate into contact with a surface of a second substrate, thereby laminating the first substrate to the second substrate. Laminates prepared comprising the water-based adhesives and according to the disclosed methods are also disclosed. | 2020-07-02 |
20200207906 | POLYURETHANE FOAM FORMING COMPOSITION INCLUDING TRIGLYCERIDES, POLYURETHANE FOAM MADE FROM THE COMPOSITION, AND METHOD OF MAKING POLYURETHANE FOAM - The present disclosure relates to a method of making polyurethane foam, the method comprising providing a polyol mixture comprising polyether polyol and unmodified vegetable oil having a hydroxyl number of less than 10; and reacting isocyanate with the polyol mixture to form a polyurethane foam, wherein the unmodified vegetable oil does not react and does not form part of the polyurethane foam. The present disclosure also relates to polyurethane formed by the method and polyurethane compositions. | 2020-07-02 |
20200207907 | WATERBORNE POLYURETHANE AND PREPARATION METHOD THEREOF - A waterborne polyurethane is provided. The waterborne polyurethane is formed by mixing a polyol, a diisocyanate, a dimethylol alkyl acid, and an epoxy resin into a mixture, and polymerizing the mixture. When the usage amount of the epoxy resin used is 1 part by weight, the usage amount of the polyol is 3 to 30 parts by weight, the usage amount of the diisocyanate is 1 to 10 parts by weight, and the usage amount of the dimethylol alkyl acid is 0.1-3.0 parts by weight. The epoxy resin includes an epoxy resin having a cyclic structure, a triacylglycerol having an epoxy group, or a combination thereof. | 2020-07-02 |
20200207908 | METHOD FOR IMPROVED STABILITY OF POLYURETHANE FOAM MADE WITH A HYDROHALOOLEFIN BLOWING AGENT - A method for producing a polyurethane foam by combining: (a) a polyol; (b) a polyisocyanate; (c) a hydrohaloolefin blowing agent; (d) an amine catalyst; and (e) a polysiloxane. | 2020-07-02 |
20200207909 | POLYMERIC MATERIAL INCLUDING A URETDIONE-CONTAINING MATERIAL, TWO-PART COMPOSITIONS, AND METHODS - The present disclosure provides a polymeric material including a reaction product of a polymerizable composition and having a solids content of 90% or greater. The polymerizable composition includes a uretdione-containing material including a reaction product of a diisocyanate reacted with itself, a first hydroxyl-containing compound having a single OH group, and a second hydroxyl-containing compound having more than one OH group. The first hydroxyl-containing compound is a primary alcohol or a secondary alcohol, plus the second hydroxyl-containing compound is a diol and the reaction product contains 0.2 to 0.5, inclusive, of diol equivalents relative to isocyanate equivalents. The present disclosure also provides a two-part composition, in which the polymeric material is included in the first part and the second part includes at least one amine. Further, a method of adhering two substrates is provided, including obtaining a two-part composition; combining at least a portion of the first part with at least a portion of the second part to form a mixture; disposing at least a portion of the mixture on a first substrate; and contacting a second substrate with the mixture disposed on the first substrate. The disclosure also provides a polymeric material and a method of making a two-part composition. Advantageously, two-part compositions according to the present disclosure can be used as coatings and adhesive systems with handling and performance similar to existing two-part urethane systems, but with less sensitivity to water. | 2020-07-02 |
20200207910 | Alkoxylated Polycarboxylic Acid Esters - Alkoxylated polycarboxylic acid esters are provided obtainable by first reacting an aromatic polycarboxylic acid containing at least three carboxylic acid units or anhydrides derived therefrom, preferably an aromatic polycarboxylic acid containing three or four carboxylic acid units or anhydrides derived therefrom, more preferably an aromatic polycarboxylic acid containing three carboxylic acid units or anhydrides derived therefrom, even more preferably trimellitic acid or trimellitic acid anhydride, most preferably trimellitic acid anhydride, with an alcohol alkoxylate and in a second step reacting the resulting product with an alcohol or a mixture of alcohols, preferably with an alcohol. | 2020-07-02 |
20200207911 | ALKYLENE OXIDE DERIVATIVES, WETTING AGENT, SOLUBILIZING AGENT, AND SOLUBILIZING COMPOSITION - An alkylene oxide derivative represented by following formula (I): | 2020-07-02 |
20200207912 | PROCESS FOR THE CONTINUOUS PRODUCTION OF POLYETHER POLYOLS - This invention relates to a process for the continuous production of polyether polyols, polyether polyols produced by the inventive continuous process and their use in polyurethane applications. | 2020-07-02 |
20200207913 | PHOSPHONIUM BROMIDE TERMINATED POLYIMIDE WITH HIGH TENSILE PROPERTIES - A polyimide oligomer of the formula | 2020-07-02 |
20200207914 | POLYIMIDE FILM FOR DISPLAY SUBSTRATE - The present invention provides a polyimide film comprising a polyimide, of which the Int | 2020-07-02 |
20200207915 | RESIN COMPOSITION, METHOD OF PRODUCING RESIN FILM, AND METHOD OF PRODUCING ELECTRONIC DEVICE - A resin composition comprising (a) at least one resin selected from polyimides and polyimide precursors, and (b) a solvent, wherein the loss tangent (tan δ), represented by the following formula (I) and determined by a dynamic viscoelasticity measurement under the conditions of a temperature of 22° C. and an angular frequency of 10 rad/s, is 150 or more and less than 550, provides a resin composition which has no defects such as rupture of the film when the coated film is dried under reduced pressure, and has good film thickness uniformity and mechanical properties when formed into a film. | 2020-07-02 |
20200207916 | POLYETHERIMIDE FROM METAL FREE IONOMERS - A polyimide oligomer of formula (1a), (1b), a copolymer thereof, or a combination thereof | 2020-07-02 |
20200207917 | HYDROPHILIC POLYAMIDE OR POLYIMIDE - Provided are a hydrophilic polyamide and polyimide retaining characteristics particular to polyamides and polyimides, such as heat resistance. A polymeric compound is provided having a repeating unit represented by the following formula (1): | 2020-07-02 |
20200207918 | BRANCHED COPOLYMER, AND PHOTOSENSITIVE RESIN COMPOSITION, PHOTOSENSITIVE RESIN FILM AND OPTICAL DEVICE USING THE SAME - The present invention relates to a branched copolymer having a polyimide polymer block bonded to each terminal of a branched polyamide functional group, and a photosensitive resin composition including the same, a photosensitive resin film, and an optical device. | 2020-07-02 |
20200207919 | CROSSLINKING OF HYDRIDOSILOXANES WITH SILICON (II) COMPOUNDS - Cationic silicon (II) compounds catalyze reaction of organosiloxanes bearing lateral Si—H functions to crosslink the polymers. Hydridosilanes may also be prepared by this reaction. The cationic silicon (II) compounds contain a silicon (II) moiety where silicon is π-bonded to a cyclopentadienyl anion. | 2020-07-02 |
20200207920 | TOUCH SENSITIVE ELEMENT AND DISPLAY DEVICE COMPRISING THE SAME - Provided are a touch sensitive element and a display device including the same. The touch sensitive element according to an exemplary aspect of the present disclosure includes an electroactive layer formed of a linear boron nitride polymer and an electrode disposed on at least one surface of the electroactive layer. Therefore, a piezoelectricity of the electroactive layer is improved to improve vibration strength of the touch sensitive element and significantly improve heat resistance. | 2020-07-02 |
20200207921 | DIBLOCK COPOLYMER, A MANUFACTURING METHOD AND SUITED APPLICATIONS - It is provided a diblock copolymer consisting of a first block, a second block, and a linker, wherein the second block is covalently bound to the first block by the linker. Thereby, the first block is a glycerol block comprising 1 to 10 glycerol subunits that are optionally substituted, and the second block is a superhydrophobic block comprising a perfluoroether residue having at least 20 carbon atoms. | 2020-07-02 |
20200207922 | CROSS POLYMERS COMPOSED OF POLYSACCHARIDES AND POLYAMINO ACIDS, AND USES THEREOF - The present invention relates to cross polymers composed at least of polysaccharides and polyamino acids, and more particularly to hydrogels composed of said cross polymers. The invention also relates to a process for preparing them, as well as their use in the delivery of active agents for pharmaceutical, diagnostic and/or dermo-cosmetic applications. | 2020-07-02 |
20200207923 | RESIN AND INK - An ink is provided, which includes a resin, UV curable monomer, and photo initiator. The resin is formed by reacting a plurality of end capping agents with a dendrimer compound in an environment including esterification catalyst, inhibitor, and first solvent. The dendrimer compound is formed by reacting a multi-hydroxy compound and a plurality of hydroxy-containing epoxy compounds in an environment including alkaline catalyst and second solvent. The multi-hydroxy compound and the hydroxy-containing epoxy compounds have a molar ratio of 1:6 to 1:20, and the multi-hydroxy compound and the end capping agents have a molar ratio of 1:6 to 1:20. The end capping agents include acrylic acid, methacrylic acid, glycidyl methacrylate, or 2-amino acrylic acid. The resin and the UV curable monomer have a weight ratio of 100:30 to 100:5000, and the resin and the photo initiator have a weight ratio of 100:30 to 100:500. | 2020-07-02 |
20200207924 | RESIDUAL SOY FLOUR SUGARS AS CROSSLINKERS FOR ENHANCING MECHANICAL PERFORMANCE OF PROTEIN FIBERS - Disclosed is a method of crosslinking protein fibers, including wool fibers, by (i) providing a crosslinking agent including an oxidized sugar mixture having a plurality of different oxidized sugars of different molecular lengths and having at least two aldehyde groups (e.g., oxidized soy flour sugars); and (ii) infiltrating a plurality of non-crosslinked protein fibers with the crosslinking agent under conditions effective to cause protein molecules contained in the non-crosslinked protein fibers to become crosslinked. This method yields a population of crosslinked protein fibers, where the protein molecules of the non-crosslinked protein fibers include amine groups that react with the aldehyde groups of the oxidized sugars to achieve the crosslinking of the protein molecules to yield the crosslinked protein fibers. | 2020-07-02 |
20200207925 | LIGNOCELLULOSIC BIOMASS TREATMENT METHOD AND SYSTEM - There is provided a method and system of treating lignocellulose biomass for extraction of target chemical products therefrom. The method comprises pretreating the lignocellulose biomass with at least one diol in the presence of at least one acid, and optionally, water; and separating the pretreated mixture into solid and liquid products. | 2020-07-02 |
20200207926 | DILUTABLE DISPERSIONS - Low concentration surfactant emulsions and methods of making and using the same are disclosed herein. The emulsions have the benefit of employing less surfactant than conventional emulsions. Further, the emulsions are dilutable and retain their stability upon dilution. A benefit of the emulsions is that they leave a low residue, preferably no residue, on a surface after contact. | 2020-07-02 |
20200207927 | HYDROGELS DERIVED FROM ACRYLAMIDE FOR CONTROLLING CIRCULATION LOSSES AND METHODS OF FABRICATION THEREOF - Acrylamide-derived hydrogels and methods of fabrication thereof from an acrylic monomer, a crosslinking agent comprising an organosilicon compound, a polymerization initiator, a solvent and a polymerization accelerator, as well as their use in controlling circulation losses. The obtained hydrogels interact with the walls of the reservoir and exhibits an increase in viscosity, either at delayed times or in response to a given stimulus, such as changes in temperature, pressure, pH, salinity, using a simple and easily scalable methodology. | 2020-07-02 |
20200207928 | SOLID STATE ELECTRODES AND SENSORS - Analyte-insensitive materials comprising polymerizable monomers suitable for use in forming a hydrophilic, cross-linked gel comprising on the surface of a substrate for an electrode. | 2020-07-02 |
20200207929 | Super Absorbent Polymer Granules And Preparation Method Thereof - The present disclosure relates to a preparation method of super absorbent polymer granules and super absorbent polymer granules prepared according to the same. More specifically, the preparation method of the present disclosure includes the steps of: forming a hydrogel polymer by carrying out a thermal polymerization or a photopolymerization of a monomer composition including a water-soluble ethylene-based unsaturated monomer and a polymerization initiator; drying and pulverizing the hydrogel polymer; classifying the pulverized polymer into a first fine powder having a particle size of 150 μm or less, and a base resin having a particle size of 150 μm or more and 850 μm or less; surface-crosslinking the base resin; classifying the surface crosslinked base resin to separate a second fine powder having a particle size of 150 μm or less; and forming fine powder granules by mixing the first fine powder, the second fine powder, and silica in a wet state. | 2020-07-02 |
20200207930 | METHOD FOR PREPARING BIODEGRADABLE POLYMER MICROPARTICLES, AND BIODEGRADABLE POLYMER MICROPARTICLES PREPARED THEREBY - Provided are: a method for preparing biodegradable polymer microparticles and, particularly, porous microparticles of a biodegradable polymer; and biodegradable polymer microparticles prepared thereby, particularly, porous microparticles of a biodegradable polymer. | 2020-07-02 |
20200207931 | WATER-SOLUBLE MATRIX, PRE-MOLDED ARTICLE CONTAINING RESIN PARTICLES, AND METHOD FOR PRODUCING RESIN PARTICLES - Provided are: a water-soluble matrix whose melt-kneading temperature can be adjusted according to the melting point or glass transition temperature of a resin; a pre-molded article in which resin particles are dispersed in the water-soluble matrix; and a method for producing resin particles. This production method includes melt-kneading a water-soluble matrix containing a modified polyvinyl alcohol-based resin and a water-soluble saccharide at a weight ratio of the former/the latter=from 99/1 to 50/50 and a thermoplastic resin, and bringing the pre-molded article in which the resin particles are dispersed into contact with an aqueous solvent to elute the matrix. The modified polyvinyl alcohol-based resin contains in a side chain thereof an alkyl group including at least one hydroxyl group (for example, a 1,2-dihydroxyalkyl group). | 2020-07-02 |
20200207932 | METHOD FOR BIOFABRICATING COMPOSITE MATERIAL - The invention is directed to a method for producing a composite material comprising a biofabricated material and a secondary component. The secondary component may be a porous material, such as a sheet of paper, cellulose, or fabric that has been coated or otherwise contacted with the biofabricated material. The biofabricated material comprises a uniform network of crosslinked collagen fibrils and provides strength, elasticity and an aesthetic appearance to the composite material. | 2020-07-02 |
20200207933 | CHALCOGENIDE HYBRID INORGANIC/ORGANIC POLYMER (CHIP) MATERIALS AS IMPROVED CROSSLINKING AGENTS FOR VULCANIZATION - Methods of vulcanization using a high content sulfur polymer, instead of elemental sulfur, have been developed. These high sulfur content polymers are referred to as Chalcogenide Hybrid Inorganic/Organic Polymers (CHIP) materials and have good polymer compatibility in that they are soluble in a number of polymers. Furthermore, CHIP materials may have weaker bonds than the S—S bonds of elemental sulfur and thus provide for a higher crosslinking efficiency vulcanization. | 2020-07-02 |
20200207934 | HEAT-SHRINKABLE POLYESTER FILM AND PACKAGE - The invention provides a heat-shrinkable polyester film which has heat shrinkage properties in a main shrinkage direction that is the longitudinal direction, in which a variation in shrinkage in the width direction is small in the width direction, and wrinkles and strains are less likely to be generated at the time of shrinkage finishing due to a small molecular orientation angle. The heat-shrinkable polyester film is characterized by (1) a hot-water shrinkage of 50% or more in a main shrinkage direction when treated for 10 seconds in water at 98° C.; (2) a variation of hot-water shrinkages in a direction orthogonal to the main shrinkage direction for samples treated for 10 seconds in water at 98° C. of 5% or less; (3) an absolute value of a molecular orientation angle of 15 degrees or less; and (4) a refractive index difference between the main shrinking and orthogonal directions of 0.06 or more. | 2020-07-02 |
20200207935 | STRETCHABLE FILM AND METHOD FOR FORMING THE SAME - A stretchable film is made of, at least as a top surface of the stretchable film, a cured product of a stretchable film material containing a silicone polyurethane resin. The top surface of the stretchable film has a repeated uneven pattern formed with depths of 0.1 μm to 2 mm and pitches of 0.1 μm to 5 mm. Thus, the present invention provides a stretchable film having excellent stretchability, with the film top surface being excellent in water repellency and free from sticking; and a method for forming the stretchable film. | 2020-07-02 |
20200207936 | SHEET MOLDING COMPOUND, PREPREG, AND FIBER-REINFORCED COMPOSITE MATERIAL - A sheet molding compound includes an epoxy resin composition meeting (I) and/or (II): (I) a component has a hydroxy group equivalent weight of 20 to 120, and (II) carbon fibers are bundle-shaped aggregates of discontinuous carbon fibers such that in a plane that has a largest width perpendicular to an alignment direction of the carbon fibers, two acute angles, referred to as angle a and angle b, formed between the alignment direction of the carbon fibers and sides formed by arrays of both ends of the carbon fibers in the bundle-shaped aggregates are 2° or more and 30° or less, the epoxy resin composition has a viscosity at 30° C. of 3.0×104 Pa·s or more and 1.0×106 Pa·s or less, and the epoxy resin composition has a viscosity at 120° C. of 1.0×102 Pa·s or more and 5.0×103 Pa·s or less. | 2020-07-02 |
20200207937 | NEW FOAM WITH IMPROVED EXPANSION BEHAVIOUR WHEN USED IN THIN LAYERS - A thermally expandable composition, including: (a) at least one polymer P, cross-linkable by a free-radical initiator; (b) at least one acrylate A; (c) at least one free-radical initiator; (d) at least one blowing agent; and (e) at least one surfactant, whereby the surfactant is a sulfonate salt. The thermally expandable composition is able to provide sufficient expansion behaviour when used in the form of a thin layer and is especially suitable for baffle and/or reinforcement elements. | 2020-07-02 |